{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:50:51Z","timestamp":1789753851855,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00253-022-12154-z","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T03:35:56Z","timestamp":1662780956000},"page":"6689-6700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model"],"prefix":"10.1007","volume":"106","author":[{"given":"Qiaomai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-0593","authenticated-orcid":false,"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,10]]},"reference":[{"key":"12154_CR1","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/j.eclinm.2020.100420","volume":"24","author":"ZI Abdali","year":"2020","unstructured":"Abdali ZI, Roberts TE, Barton P, Hawkey PM (2020) Economic evaluation of faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection. EClinicalMedicine 24:100420. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100420","journal-title":"EClinicalMedicine"},{"key":"12154_CR2","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","volume":"38","author":"F Barbut","year":"2000","unstructured":"Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38:2386\u20132388. https:\/\/doi.org\/10.1128\/JCM.38.6.2386-2388.2000","journal-title":"J Clin Microbiol"},{"key":"12154_CR3","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/AAC.02262-13","volume":"58","author":"CM Bassis","year":"2014","unstructured":"Bassis CM, Theriot CM, Young VB (2014) Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother 58:2767\u20132774. https:\/\/doi.org\/10.1128\/AAC.02262-13","journal-title":"Antimicrob Agents Chemother"},{"key":"12154_CR4","doi-asserted-by":"publisher","first-page":"e1061","DOI":"10.1002\/mbo3.1061","volume":"9","author":"G Bassotti","year":"2020","unstructured":"Bassotti G, Marchegiani A, Marconi P, Fettucciari K (2020) The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses. Microbiologyopen 9:e1061. https:\/\/doi.org\/10.1002\/mbo3.1061","journal-title":"Microbiologyopen"},{"key":"12154_CR5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"12154_CR6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/JB.01492-12","volume":"195","author":"L Bouillaut","year":"2013","unstructured":"Bouillaut L, Self WT, Sonenshein AL (2013) Proline-dependent regulation of Clostridium difficile Stickland metabolism. J Bacteriol 195:844\u2013854. https:\/\/doi.org\/10.1128\/JB.01492-12","journal-title":"J Bacteriol"},{"key":"12154_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ajg.2012.60","volume":"107","author":"LJ Brandt","year":"2012","unstructured":"Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107:1079\u20131087. https:\/\/doi.org\/10.1038\/ajg.2012.60","journal-title":"Am J Gastroenterol"},{"key":"12154_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335\u2013336. https:\/\/doi.org\/10.1038\/nmeth.f.303","journal-title":"Nat Methods"},{"key":"12154_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1086\/525047","volume":"197","author":"JY Chang","year":"2008","unstructured":"Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB (2008) Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197:435\u2013438. https:\/\/doi.org\/10.1086\/525047","journal-title":"J Infect Dis"},{"key":"12154_CR10","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","volume":"135","author":"X Chen","year":"2008","unstructured":"Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP (2008) A mouse model of Clostridium difficile-associated disease. Gastroenterology 135:1984\u20131992. https:\/\/doi.org\/10.1053\/j.gastro.2008.09.002","journal-title":"Gastroenterology"},{"key":"12154_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nature25178","volume":"553","author":"J Collins","year":"2018","unstructured":"Collins J, Robinson C, Danhof H, Knetsch CW, van Leeuwen HC, Lawley TD, Auchtung JM, Britton RA (2018) Dietary trehalose enhances virulence of epidemic Clostridium difficile. Nature 553:291\u2013294. https:\/\/doi.org\/10.1038\/nature25178","journal-title":"Nature"},{"key":"12154_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40168-022-01284-1","volume":"10","author":"JJ Dawkins","year":"2022","unstructured":"Dawkins JJ, Allegretti JR, Gibson TE, McClure E, Delaney M, Bry L, Gerber GK (2022) Gut metabolites predict Clostridioides difficile recurrence. Microbiome 10:87. https:\/\/doi.org\/10.1186\/s40168-022-01284-1","journal-title":"Microbiome"},{"key":"12154_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5217\/ir.2014.12.4.299","volume":"12","author":"YS Doh","year":"2014","unstructured":"Doh YS, Kim YS, Jung HJ, Park YI, Mo JW, Sung H, Lee KJ, Seo YK, Moon JS, Hong SW (2014) Long-term clinical outcome of Clostridium difficile infection in hospitalized patients: a single center study. Intest Res 12:299\u2013305. https:\/\/doi.org\/10.5217\/ir.2014.12.4.299","journal-title":"Intest Res"},{"key":"12154_CR14","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar RC (2013) UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10:996\u2013998. https:\/\/doi.org\/10.1038\/nmeth.2604","journal-title":"Nat Methods"},{"key":"12154_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/JIR.S287096","volume":"14","author":"K Fettucciari","year":"2021","unstructured":"Fettucciari K, Fruganti A, Marchegiani A, Brancorsini S, Marconi P, Bassotti G (2021) Proinflammatory cytokines: possible accomplices for the systemic effects of Clostridioides difficile toxin B. J Inflamm Res 14:57\u201362. https:\/\/doi.org\/10.2147\/JIR.S287096","journal-title":"J Inflamm Res"},{"key":"12154_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/1040841X.2019.1700905","volume":"45","author":"Y Gao","year":"2019","unstructured":"Gao Y, Li H, Yang H, Su J, Huang L (2019) The current novel therapeutic regimens for Clostridium difficile infection (CDI) and the potentials of traditional Chinese medicine in treatment of CDI. Crit Rev Microbiol 45:729\u2013742. https:\/\/doi.org\/10.1080\/1040841X.2019.1700905","journal-title":"Crit Rev Microbiol"},{"key":"12154_CR17","doi-asserted-by":"publisher","first-page":"127113","DOI":"10.1016\/j.micres.2022.127113","volume":"263","author":"Y Gao","year":"2022","unstructured":"Gao Y, Ma L, Su J (2022) Host and microbial-derived metabolites for Clostridioides difficile infection: contributions, mechanisms and potential applications. Microbiol Res 263:127113. https:\/\/doi.org\/10.1016\/j.micres.2022.127113","journal-title":"Microbiol Res"},{"key":"12154_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.micinf.2015.09.008","volume":"18","author":"S Gu","year":"2016","unstructured":"Gu S, Chen Y, Zhang X, Lu H, Lv T, Shen P, Lv L, Zheng B, Jiang X, Li L (2016) Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes Infect 18:30\u201338. https:\/\/doi.org\/10.1016\/j.micinf.2015.09.008","journal-title":"Microbes Infect"},{"key":"12154_CR19","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.2147\/IDR.S281274","volume":"13","author":"SL Gu","year":"2020","unstructured":"Gu SL, Gong Y, Zhang J, Chen Y, Wu Z, Xu Q, Fang Y, Wang J, Tang LL (2020) Effect of the short-term use of fluoroquinolone and beta-lactam antibiotics on mouse gut microbiota. Infect Drug Resist 13:4547\u20134558. https:\/\/doi.org\/10.2147\/IDR.S281274","journal-title":"Infect Drug Resist"},{"key":"12154_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13561-021-00301-7","volume":"11","author":"LH Hammeken","year":"2021","unstructured":"Hammeken LH, Baunwall SMD, Hvas CL, Ehlers LH (2021) Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review. Health Econ Rev 11:3. https:\/\/doi.org\/10.1186\/s13561-021-00301-7","journal-title":"Health Econ Rev"},{"key":"12154_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dkw383","volume":"72","author":"S Isaac","year":"2017","unstructured":"Isaac S, Scher JU, Djukovic A, Jimenez N, Littman DR, Abramson SB, Pamer EG, Ubeda C (2017) Short- and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother 72:128\u2013136. https:\/\/doi.org\/10.1093\/jac\/dkw383","journal-title":"J Antimicrob Chemother"},{"key":"12154_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.anaerobe.2017.08.003","volume":"48","author":"ZD Jiang","year":"2017","unstructured":"Jiang ZD, Alexander A, Ke S, Valilis EM, Hu S, Li B, DuPont HL (2017) Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Anaerobe 48:110\u2013114. https:\/\/doi.org\/10.1016\/j.anaerobe.2017.08.003","journal-title":"Anaerobe"},{"key":"12154_CR23","doi-asserted-by":"publisher","first-page":"e101267","DOI":"10.1371\/journal.pone.0101267","volume":"9","author":"RL Jump","year":"2014","unstructured":"Jump RL, Polinkovsky A, Hurless K, Sitzlar B, Eckart K, Tomas M, Deshpande A, Nerandzic MM, Donskey CJ (2014) Metabolomics analysis identifies intestinal microbiota-derived biomarkers of colonization resistance in clindamycin-treated mice. PLoS ONE 9:e101267. https:\/\/doi.org\/10.1371\/journal.pone.0101267","journal-title":"PLoS ONE"},{"issue":"27\u201334","key":"12154_CR24","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/j.chembiol.2018.10.003","volume":"26","author":"JD Kang","year":"2019","unstructured":"Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee IK, Yun BS, Matsuzaki K, Furukawa M, Min HK, Bajaj JS, Zhou H, Hylemon PB (2019) Bile acid 7alpha-dehydroxylating gut bacteria secrete antibiotics that inhibit Clostridium difficile: role of secondary bile acids. Cell Chem Biol 26(27\u201334):e24. https:\/\/doi.org\/10.1016\/j.chembiol.2018.10.003","journal-title":"Cell Chem Biol"},{"issue":"Pt 7","key":"12154_CR25","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1099\/13500872-145-7-1683","volume":"145","author":"S Karlsson","year":"1999","unstructured":"Karlsson S, Burman LG, Akerlund T (1999) Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiol (reading) 145(Pt 7):1683\u20131693. https:\/\/doi.org\/10.1099\/13500872-145-7-1683","journal-title":"Microbiol (reading)"},{"key":"12154_CR26","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1099\/mic.0.2008\/019778-0","volume":"154","author":"S Karlsson","year":"2008","unstructured":"Karlsson S, Burman LG, Akerlund T (2008) Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism. Microbiol (reading) 154:3430\u20133436. https:\/\/doi.org\/10.1099\/mic.0.2008\/019778-0","journal-title":"Microbiol (reading)"},{"issue":"Suppl 6","key":"12154_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1469-0691.12046","volume":"18","author":"CP Kelly","year":"2012","unstructured":"Kelly CP (2012) Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 18(Suppl 6):21\u201327. https:\/\/doi.org\/10.1111\/1469-0691.12046","journal-title":"Clin Microbiol Infect"},{"key":"12154_CR28","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","volume":"116","author":"CR Kelly","year":"2021","unstructured":"Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021) ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol 116:1124\u20131147. https:\/\/doi.org\/10.14309\/ajg.0000000000001278","journal-title":"Am J Gastroenterol"},{"key":"12154_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41575-020-0350-4","volume":"18","author":"A Khoruts","year":"2021","unstructured":"Khoruts A, Staley C, Sadowsky MJ (2021) Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol 18:67\u201380. https:\/\/doi.org\/10.1038\/s41575-020-0350-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12154_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT (2015) Clostridium difficile infection. N Engl J Med 372:1539\u20131548. https:\/\/doi.org\/10.1056\/NEJMra1403772","journal-title":"N Engl J Med"},{"key":"12154_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.hbpd.2019.12.008","volume":"19","author":"JM Lou","year":"2020","unstructured":"Lou JM, Ren ZG, Li A, Rao BC, Yu ZJ (2020) Fecal microbiota transplantation has therapeutic effects on chronic hepatits B patients via altering composition of gut microbiota. Hepatobiliary Pancreat Dis Int 19:486\u2013487. https:\/\/doi.org\/10.1016\/j.hbpd.2019.12.008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"12154_CR32","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Magoc","year":"2011","unstructured":"Magoc T, Salzberg SL (2011) Flash: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957\u20132963. https:\/\/doi.org\/10.1093\/bioinformatics\/btr507","journal-title":"Bioinformatics"},{"key":"12154_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.gastro.2011.11.037","volume":"142","author":"E Mattila","year":"2012","unstructured":"Mattila E, Uusitalo-Seppala R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppala M, Mattila PS, Anttila VJ, Arkkila P (2012) Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 142:490\u2013496. https:\/\/doi.org\/10.1053\/j.gastro.2011.11.037","journal-title":"Gastroenterology"},{"key":"12154_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis 66:987\u2013994. https:\/\/doi.org\/10.1093\/cid\/ciy149","journal-title":"Clin Infect Dis"},{"key":"12154_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41586-021-03502-6","volume":"593","author":"KM Pruss","year":"2021","unstructured":"Pruss KM, Sonnenburg JL (2021) C. difficile exploits a host metabolite produced during toxin-mediated disease. Nature 593:261\u2013265. https:\/\/doi.org\/10.1038\/s41586-021-03502-6","journal-title":"Nature"},{"key":"12154_CR36","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jhep.2012.11.023","volume":"58","author":"EM Quigley","year":"2013","unstructured":"Quigley EM, Stanton C, Murphy EF (2013) The gut microbiota and the liver Pathophysiological and Clinical Implications. J Hepatol 58:1020\u20131027. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.023","journal-title":"J Hepatol"},{"key":"12154_CR37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jama.2019.3849","volume":"323","author":"K Rao","year":"2020","unstructured":"Rao K, Malani PN (2020) Diagnosis and treatment of Clostridioides (Clostridium) difficile infection in adults in 2020. JAMA 323:1403\u20131404. https:\/\/doi.org\/10.1001\/jama.2019.3849","journal-title":"JAMA"},{"key":"12154_CR38","doi-asserted-by":"publisher","first-page":"e00974","DOI":"10.1128\/mBio.00974-15","volume":"6","author":"AM Schubert","year":"2015","unstructured":"Schubert AM, Sinani H, Schloss PD (2015) Antibiotic-induced alterations of the murine gut microbiota and subsequent effects on colonization resistance against Clostridium difficile. mBio 6:e00974. https:\/\/doi.org\/10.1128\/mBio.00974-15","journal-title":"mBio"},{"key":"12154_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5217\/ir.2016.14.1.83","volume":"14","author":"JY Shin","year":"2016","unstructured":"Shin JY, Ko EJ, Lee SH, Shin JB, Kim SI, Kwon KS, Kim HG, Shin YW, Bang BW (2016) Refractory pseudomembranous colitis that was treated successfully with colonoscopic fecal microbial transplantation. Intest Res 14:83\u201388. https:\/\/doi.org\/10.5217\/ir.2016.14.1.83","journal-title":"Intest Res"},{"key":"12154_CR40","doi-asserted-by":"publisher","unstructured":"Sierocka A, Kiersnowska Z, Lemiech-Mirowska E, Marczak M (2021) Costs associated with the treatment of Clostridioides difficile infections. Int J Environ Res Public Health 18. https:\/\/doi.org\/10.3390\/ijerph18147647","DOI":"10.3390\/ijerph18147647"},{"key":"12154_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5009\/gnl18071","volume":"13","author":"JH Song","year":"2019","unstructured":"Song JH, Kim YS (2019) Recurrent Clostridium difficile infection: risk factors, treatment, and prevention. Gut Liver 13:16\u201324. https:\/\/doi.org\/10.5009\/gnl18071","journal-title":"Gut Liver"},{"key":"12154_CR42","doi-asserted-by":"publisher","unstructured":"Theriot CM, Bowman AA, Young VB (2016) Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 1. https:\/\/doi.org\/10.1128\/mSphere.00045-15","DOI":"10.1128\/mSphere.00045-15"},{"key":"12154_CR43","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1038\/ncomms4114","volume":"5","author":"CM Theriot","year":"2014","unstructured":"Theriot CM, Koenigsknecht MJ, Carlson PE Jr, Hatton GE, Nelson AM, Li B, Huffnagle GB, J ZL, Young VB (2014) Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5:3114. https:\/\/doi.org\/10.1038\/ncomms4114","journal-title":"Nat Commun"},{"key":"12154_CR44","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1128\/AAC.04296-14","volume":"59","author":"CM Theriot","year":"2015","unstructured":"Theriot CM, Schumacher CA, Bassis CM, Seekatz AM, Young VB (2015) Effects of tigecycline and vancomycin administration on established Clostridium difficile infection. Antimicrob Agents Chemother 59:1596\u20131604. https:\/\/doi.org\/10.1128\/AAC.04296-14","journal-title":"Antimicrob Agents Chemother"},{"key":"12154_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-micro-091014-104115","volume":"69","author":"CM Theriot","year":"2015","unstructured":"Theriot CM, Young VB (2015) Interactions between the gastrointestinal microbiome and Clostridium difficile. Annu Rev Microbiol 69:445\u2013461. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104115","journal-title":"Annu Rev Microbiol"},{"key":"12154_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368:407\u2013415. https:\/\/doi.org\/10.1056\/NEJMoa1205037","journal-title":"N Engl J Med"},{"key":"12154_CR47","doi-asserted-by":"publisher","first-page":"9645","DOI":"10.1038\/s41598-017-09961-0","volume":"7","author":"Q Xu","year":"2017","unstructured":"Xu Q, Chen Y, Gu S, Lv T, Zheng B, Shen P, Quan J, Fang Y, Li L (2017) Hospital-acquired Clostridium difficile infection in mainland China: a seven-year (2009\u20132016) retrospective study in a large university hospital. Sci Rep 7:9645. https:\/\/doi.org\/10.1038\/s41598-017-09961-0","journal-title":"Sci Rep"},{"key":"12154_CR48","doi-asserted-by":"publisher","unstructured":"Xu Q, Gu S, Chen Y, Quan J, Lv L, Chen D, Zheng B, Xu L, Li L (2018) Protective effect of Pediococcus pentosaceus LI05 against Clostridium difficile infection in a mouse model. Front Microbiol 9. https:\/\/doi.org\/10.3389\/fmicb.2018.02396","DOI":"10.3389\/fmicb.2018.02396"},{"key":"12154_CR49","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/cpr.13028","volume":"54","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhu J, Feng B, Lin F, Zhou J, Liu J, Shi X, Lu X, Pan Q, Yu J, Zhang Y, Li L, Cao H (2021) Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8(+) T cells in lipopolysaccharide-induced acute lung injury in mice. Cell Prolif 54:e13028. https:\/\/doi.org\/10.1111\/cpr.13028","journal-title":"Cell Prolif"},{"key":"12154_CR50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.hbpd.2021.03.004","volume":"20","author":"D Yan","year":"2021","unstructured":"Yan D, Huang YD, Chen YB, Lv T, Zhu CX, Huang JR, Li LJ (2021) Prediction of Clostridium difficile infection based on gut microbial traits in patients with Clostridium difficile colonization. Hepatobiliary Pancreat Dis Int 20:298\u2013300. https:\/\/doi.org\/10.1016\/j.hbpd.2021.03.004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"12154_CR51","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3389\/fmicb.2018.01967","volume":"9","author":"J Ye","year":"2018","unstructured":"Ye J, Lv L, Wu W, Li Y, Shi D, Fang D, Guo F, Jiang H, Yan R, Ye W, Li L (2018) Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol 9:1967. https:\/\/doi.org\/10.3389\/fmicb.2018.01967","journal-title":"Front Microbiol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-022-12154-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T09:04:56Z","timestamp":1664787896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-022-12154-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,10]]},"references-count":51,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["12154"],"URL":"https:\/\/doi.org\/10.1007\/s00253-022-12154-z","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,10]]},"assertion":[{"value":"22 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All experiments were approved by the Animal Care Committee of the First Affiliated Hospital, Zhejiang University (No. 2021\u20137-2). This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}